Singh Shawn
SEC CIK 1412071 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| VTGN | Vistagen Therapeutics, Inc. | Pres, CEO, Dir | 54.8K | $102.0K | — | 11 | 2021-06-30 | 2026-06-30 |
Most active insiders at VTGN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Prince Joshua S. | COO | — | — |
| 2 | Adler Reid G. | CLO | — | — |
| 3 | Tressler Nick B. | CFO | — | — |
| 4 | Singh Shawn | Pres, CEO, Dir | — | — |
Transactions 11
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-02 16:16 | 2026-06-30 | VTGN | Vistagen Therapeutics, Inc. | Singh Shawn | Pres, CEO, Dir | A - Grant | $0.1921 | +36.8K | 54.8K | +204% | +$7,073 | |
| 2025-07-01 | 2025-06-30 | VTGN | Vistagen Therapeutics, Inc. | Singh Shawn | Pres, CEO, Dir | A - Grant | $1.70 | +7,541 | 18.0K | +72% | +$12.8K | |
| 2024-07-02 | 2024-06-28 | VTGN | Vistagen Therapeutics, Inc. | Singh Shawn | CEO, Dir | A - Grant | $2.96 | +4,854 | 10.5K | +86% | +$14.4K | |
| 2024-01-03 | 2023-12-29 | VTGN | Vistagen Therapeutics, Inc. | Singh Shawn | CEO, Dir | A - Grant | $1.72 | +167 | 5,633 | +3% | +$287.24 | |
| 2023-07-05 | 2023-06-30 | VTGN | Vistagen Therapeutics, Inc. | Singh Shawn | CEO, Dir | A - Grant | $1.59 | +167 | 5,466 | +3% | +$265.53 | |
| 2023-01-03 | 2022-12-30 | VTGN | Vistagen Therapeutics, Inc. | Singh Shawn | CEO, Dir | A - Grant | $0.09 | +5,000 | 159.0K | +3% | +$450 | |
| I | 2022-08-18 | 2022-08-17 | VTGN | Vistagen Therapeutics, Inc. | Singh Shawn | CEO, Dir | P - Purchase | $0.17 | +600.0K | 626.2K | +2,287% | +$102.0K |
| 2022-07-15 | 2022-06-30 | VTGN | Vistagen Therapeutics, Inc. | Singh Shawn | CEO, Dir | A - Grant | $0.75 | +5,000 | 154.0K | +3% | +$3,750 | |
| D | 2022-05-16 | 2022-05-12 | VTGN | Vistagen Therapeutics, Inc. | Singh Shawn | CEO, Dir | M - OptEx | $1.00 | +100.0K | 149.0K | +204% | +$100.0K |
| 2022-01-03 | 2021-12-31 | VTGN | Vistagen Therapeutics, Inc. | Singh Shawn | CEO, Dir | A - Grant | $1.66 | +3,623 | 49.0K | +8% | +$6,014 | |
| 2021-07-02 | 2021-06-30 | VTGN | Vistagen Therapeutics, Inc. | Singh Shawn | CEO, Dir | A - Grant | $1.95 | +5,000 | 45.4K | +12% | +$9,750 |
Purchase Sale Sale after option exercise All abbreviations